Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Nu-Med Plus' Shares Outstanding (Weighted Average) history spans 11 years, with the latest figure at $73.4 million for Q4 2021.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 34.6% to $73.4 million in Q4 2021 year-over-year; TTM through Dec 2021 was $73.4 million, a 34.6% increase, with the full-year FY2021 number at $73.4 million, up 34.6% from a year prior.
  • Shares Outstanding (Weighted Average) hit $73.4 million in Q4 2021 for Nu-Med Plus, down from $79.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NUMD hit a ceiling of $79.3 million in Q1 2021 and a floor of $34.2 million in Q2 2017.
  • Historically, Shares Outstanding (Weighted Average) has averaged $49.4 million across 5 years, with a median of $45.3 million in 2019.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 6.16% in 2017 and later soared 70.45% in 2021.
  • Tracing NUMD's Shares Outstanding (Weighted Average) over 5 years: stood at $37.5 million in 2017, then grew by 11.55% to $41.8 million in 2018, then grew by 9.0% to $45.5 million in 2019, then grew by 19.69% to $54.5 million in 2020, then skyrocketed by 34.6% to $73.4 million in 2021.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NUMD at $73.4 million in Q4 2021, $79.3 million in Q3 2021, and $79.3 million in Q2 2021.